论文部分内容阅读
目的观察倍他司汀联合银杏黄铜苷治疗血管性眩晕的治疗效果。方法 143例血管性眩晕患者随机分为治疗组(75例),和对照组(68例)。治疗组给以倍他司汀和,银杏黄酮苷注射液,静脉滴注(糖尿病患者改用0.9%氯化钠)每日1次,14d为1个疗程;对照组给予低分子右旋糖苷,复方丹参注射液静脉滴注,每日1次,14d为1个疗程。结果治疗组和对照组的有效率分别为96.00%(72/75)和77.94%(53/68),差异有统计学意义(P<0.05)。结论倍他司汀联合银杏黄酮苷治疗血管性眩晕疗效显著,且安全可靠,无明显不良反应,。
Objective To observe the therapeutic effect of betahistine combined with ginsenoside on vascular vertigo. Methods 143 patients with vascular vertigo were randomly divided into treatment group (75 cases) and control group (68 cases). The patients in the treatment group were treated with betahistine and ginkgo flavonoid glycosides injection once daily (intravenous infusion of 0.9% sodium chloride in diabetic patients), and once a day for 14 days. The control group was given low molecular weight dextran, Compound Danshen injection intravenously 1 day, 14d for a course of treatment. Results The effective rates of the treatment group and the control group were 96.00% (72/75) and 77.94% (53/68), respectively, with significant difference (P <0.05). Conclusion Betatine combined with ginkgo flavonoid glycosides treatment of vascular vertigo significant effect, and safe and reliable, no significant adverse reactions.